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ABSTRACT

ARTICLE HISTORY

In this narrative review, we will discuss some of the significant risks and dramatic consequences that
are associated with epilepsy: depression, suicide, seizure-related injuries, and mortality, both in adults
and in children. Considering the high prevalence of depression among people with epilepsy (PWE),
routine and periodic screening of all PWE for early detection and appropriate management of depression is recommended. PWE should be screened for suicidal ideation regularly and when needed,
patients should be referred for a psychiatric evaluation and treatment. When starting an antiepileptic
drug (AED) or switching from one to another AED, patients should be advised to report to their treating physician any change in their mood and existence of suicidal ideation. The risk of injuries for the
general epilepsy population is increased only moderately. The risk is higher in selected populations
attending epilepsy clinics and referral centers. This being said, there are PWE that may suffer frequent,
severe, and sometimes even life-threatening seizure-related injuries. The most obvious way to reduce
risk is to strive for improved seizure control. Finally, PWE have a 2–3 times higher mortality rate than
the general population. Deaths in PWE may relate to the underlying cause of epilepsy, to seizures
(including sudden unexpected death in epilepsy [SUDEP] and seizure related injuries) and to status
epilepticus, as well as to other conditions that do not appear directly related to epilepsy. Improving
seizure control and patient education may be the most important measures to reduce epilepsy related
mortality in general and SUDEP in particular.

Received 6 February 2020
Revised 9 May 2020
Accepted 17 May 2020

1. Introduction
Epilepsy is a chronic neurological condition that affects people of all ages and has no geographic, social, or racial boundaries. It is a wide-reaching and complex illness, affecting
more than 70 million people worldwide and can manifest in
a variety of forms, patterns, and severities1. Management
varies by region due to the availability of diagnostic modalities and medications1; however, antiepileptic drugs (AEDs)
are the mainstay of treatment. In spite of this, AEDs fail to
control seizures in about one-third of patients with epilepsy.
Patients with drug-resistant epilepsy account for most of the
burden of epilepsy, because of the substantial frequencies at
which they experience comorbid medical and psychological
conditions, and increased risk of injury and mortality, and,
ultimately, a decreased life expectancy2. While there is plenty
of evidence that has been made available of the risks associated with epilepsy, more attention should be devoted to the
severe consequences of this common condition. In this narrative review, we will discuss some of the dramatic and severe
consequences that are associated with epilepsy; these
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include depression, suicide, physical injuries, and mortality,
both in adults and in children (Table 1). Physicians, who are
taking care of patients with epilepsy, should focus not only
on controlling their seizures but also on preventing these
consequences.

2. Depression in people with epilepsy
Depression is prevalent in people with epilepsy (PWE). A systematic review and meta-analysis revealed a 23.1% (95% confidence interval: 20.6–28.31%)3 prevalence of active
depression in PWE, which is about 4–5 times higher than
that in the general population4 (Table 1). In a populationbased study, the average lifetime and 12-month prevalence
estimates of major depressive episodes were 14.6% and
5.5%, respectively in the 10 highest-income countries, and
11.1% and 5.9% in the eight countries with low- to middleincome4. Depression is often associated with work absenteeism, increased utilization of health care services and direct
and indirect medical costs5,6. In addition, depression worsens
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Table 1. Rate of depression, suicide, injuries, mortality and SUDEP in PWE compared to general population.
Depression
Suicide
Seizure-related injuries
Main features

High prevalence of
depression
among PWE3,4

Suicide attempts occur
with increased
frequency in PWE15

People with epilepsy vs
Controls
(general population)

Prevalence of active
depression is 23.1%
in PWE, 4–5 times
more than the
general population3,4

Completed suicide
among PWE is
(0.5%), and among
general
population (0.01%)15

Population-based
studies: risk of
injuries among PWE
shows only a
moderate
increase21,25
1. Prevalence of severe
injuries in PWE is
14.9% vs (13.3%) in
the general
population24
2. Incidence of injuries
in PWE is 20.6% vs
16.1% in the general
population25

Mortality
Highest mortality rate
found in PWE with
epileptic
encephalopathies39
intellectual disability
or cerebral palsy41
PWE have a 2–3 times
higher mortality rate
than the general
population36

SUDEP
Children are equally at
risk to adults
for SUDEP84

SUDEP most common
cause of epilepsyrelated death, 27-fold
higher rate than
in controls50

Abbreviations. PWE, patients with epilepsy; SUDEP, Sudden unexpected death in epilepsy.

the quality of life, is associated with subjective cognitive
impairment, and may even lead to seizure aggravation (e.g.
due to poor drug adherence in the affected patients)7–9.
Interestingly, the apparent cultural, demographic, religious,
and ethnic diversity in the world has not affected this comorbidity significantly10. However, depression is often under-recognized and improperly treated in PWE10. Considering the
high prevalence of depression among PWE, particularly in
women, routine and periodic screening of all PWE for early
detection and appropriate management of depression is
recommended10.
On the other hand, people with a history of depression
have a four- to seven-fold higher risk of developing epilepsy11. A bidirectional relationship between depression and
epilepsy has been suggested by several population-based
studies and is also supported by many experimental studies12. For instance, a marked reduction in central levels of
neurosteroids has been described in patients who develop
status epilepticus13, and among them allopregnanolone has
an established role in depression14. Structural, neuropathological, and neurotransmitter disturbances associated with
one condition may potentially facilitate the manifestations of
the other11,12. Consequently, appropriate treatment of one
condition may improve the other condition12. Selective serotonin reuptake inhibitors (SSRIs) are considered safe for the
treatment of depression in PWE12.

3. Suicide in people with epilepsy
Suicide attempts are found to occur with increased frequency in PWE (Odds ratio ¼ 3)15. In a meta-analysis15, the
pooled prevalence for suicide ideation was 23.2% (95% CI:
0.176–0.301) and for suicide attempts was 7.4% (95% CI:
0.031–0.169). The pooled rate of death due to suicide was
0.5% (95% CI: 0.002–0.016). The relationship between epilepsy and suicidality is complex. Psychiatric risk factors, epilepsy-related variables (e.g. type of epilepsy syndrome) and
exposure to certain AEDs have been associated with an
increased risk of suicide in PWE11. The complex relationship
between epilepsy and suicidality is also evident by the existence of a bidirectional relationship between these two conditions. Not only do PWE have a higher risk of suicide, but also

people with a history of suicidal ideation or behavior have a
five-fold higher risk of developing epilepsy than controls11.
In one large population-based study16, suicide attempts and
recurrent suicide attempts were associated with epilepsy
even before epilepsy manifests, suggesting a common
underlying neurobiological mechanism. In that study, both
incident and recurrent suicide attempts were associated with
incident epilepsy in the absence of AEDs and in the absence
of diagnosed psychiatric disorders, further strengthening the
evidence for a common underlying etiology16. In 2008, the
U.S. Food and Drug Administration (FDA) issued an alert
about an increased risk of suicide ideation and behavior in
patients treated with AEDs17. Although some AEDs have
been associated with treatment-emergent psychiatric disorders, that may lead to suicidal ideation and behavior, the
actual suicidal risk seems to be very low17. Suicidality in epilepsy is multifactorial, and different variables are operant in
its development. All PWE should be screened for suicidal
ideation regularly and if necessary, patients should be
referred for a psychiatric evaluation and treatment. Screening
for suicidality and suicidal behavior in PWE is feasible using
the Interactive Voice Response System CSSRS (E-CSSRS) or
the Columbia Suicide Severity Rating Scale (C-SSRS) instruments18. When starting an AED or switching from one to
other AED, patients should be advised to report to their
treating physician any change in their mood and existence
of suicidal ideation17. In addition, family members should be
involved in the discussion since they might be the ones who
first notice the changes.
It is noteworthy to mention that, generally, more than
two-thirds of patients suffering from stress-related disorders
are women, but over two-thirds of suicide completers are
men. The molecular origins of this sex dimorphism are still
quite obscure. However, several studies have identified many
stress-related genes that are regulated by stress in a sex-specific fashion. In addition, it seems that pathways and networks in male and female individuals are not equally
affected by stress exposure19. Understanding which mechanisms are more affected in men, and which in women, may
lead to the identification of sex-specific approaches and
treatment strategies.
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4. Injuries in people with epilepsy
Intuitively, the risk of injuries appears evident in conjunction
with seizures with major convulsions, falls, and loss of consciousness. Not surprisingly, such risks are also a major concern for people with epilepsy, their carers, family members
and guardians, who request adequate information from
health care providers concerning risks of injuries as part of
routine counselling20. In addition to the seizures causing
injuries, people with epilepsy may suffer injuries due to their
comorbidities (e.g. cerebral palsy, stroke or other disabilities),
their medication (causing disturbances in balance or making
patients more vulnerable to falls due to osteoporosis), or for
the same reasons as people without epilepsy.

4.1. Incidence and prevalence of injuries
4.1.1. Population-based studies
Contrary to what might be expected, population-based studies have in general found that the risk of injuries among
PWE is increased only moderately. A study of 247 patients
with newly diagnosed epilepsy from Rochester, MN, found
seizure-related injuries sufficiently serious for the patient to
seek medical attention in 39 patients (16%) on 62 occasions,
i.e. one injury per 44 person-years over a 10-year follow-up21.
In a retrospective community-based study of 819 patients
with epilepsy from Tasmania, 10% reported experiencing an
injury in the preceding year22. In the population-based childhood onset epilepsy cohort in Nova Scotia, 52 of 472
patients (11%) reported having experienced at least one serious injury during an average follow up of 24 years23. Among
studies providing comparisons with people without epilepsy,
a Canadian study based on a community health survey
reported a prevalence of injuries severe enough to limit normal activities to be 14.9% among PWE compared with 13.3%
in the general population over a 12-month period24. A subsequent Canadian study used administrative databases to
identify PWE and injuries for which medical attention was
sought25. The one-year incidence of injuries was 20.6%
among PWE compared with 16.1% among non-epilepsy controls25. In Stockholm, Sweden, 2130 patients with newly diagnosed epilepsy and 16,992 controls from the general
population were followed for on average 6.3 years in administrative registries to identify injuries leading to medical consultations26. The incidence of injuries was increased in PWE
with a Hazard Ratio of 1.71, but this was largely related to
comorbidities among PWE, as the Hazard Ratio was reduced
to 1.17 in PWE without comorbidities26. A population-based
German study used health insurance registers to identify
people with severely drug-refractory epilepsy (prescribed at
least four AEDs in an 18-month period. Compared to
matched controls from the general population, injury rates
were higher among those with drug-refractory epilepsy
(head 16% against 3%, trunk and limbs 16% against 8%)27.

4.1.2. Hospital- and clinic-based studies
A large prospective European study involved 951 epilepsy
referral patients and matched controls that were followed
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prospectively for two years28. By 24 months, 27% of the PWE
and 17% of the controls had experienced at least one injury.
In the epilepsy group, 24% of the injuries were seizurerelated28. Several other hospital/clinic-based studies have
been published from different parts of the world. A retrospective questionnaire-based study of 298 patients attending
an epilepsy outpatient clinic in Israel estimated that 30% had
ever experienced a seizure-related injury29. This translates to
one injury per 21 person-years and one serious injury per 64
person-years29. A retrospective study included 264 adults
with epilepsy attending an epilepsy clinic in Iran and 289
healthy controls30. Over a 12-month period, 47% of the
patients reported having at least one injury (relative risk
compared to controls 3.4), 14% a severe injury (relative risk
1.8)30. In a pediatric neurology clinic and referral center in
Nigeria, 125 consecutive children with epilepsy and 125 nonepilepsy controls were asked about injuries over the
preceding 12 months31. Among children with epilepsy 46%
had sustained injuries compared to 21% among controls31.

4.1.3. Types of injuries
Soft tissue injuries, sprains, dislocations, and fractures are the
most common types of injuries among people with epilepsy
as well as in the general population21,24–26,30. The head and
the extremities are the most common locations of the injuries, and falls are by far the most frequent mechanisms for
injuries in people with epilepsy26. Although far less common,
the greatest increase in risk has been reported to be with
drowning accidents, the risk being 6–18 times higher
in PWE26,32.

4.1.4. Risk factors
The risk of injuries in PWE clearly varies between different
parts of the world for many different reasons including geographical, economic, and social circumstances, availability of
effective treatments, workplace conditions and individual life
styles. Some general epilepsy-related risk factors have, however, been identified. The most consistent findings regarding
risk factors for injuries are occurrence of generalized convulsive seizures (focal to bilateral or generalized tonic-clonic
seizures)21,22,30,33, but atonic seizures and ictal falls have also
been associated with increased risks21,33,34. Intractable epilepsy, uncontrolled seizures, or high seizure frequency are
also consistent risk factors for seizure-related injuries21–23,31,35. Polytherapy with AEDs was reported to be
associated with increased risk in a few studies21,31,34
although it is not clear if polytherapy is a risk factor as such
or just a reflection of a more difficult to treat epilepsy with
poor seizure control. Some studies have identified comorbidities as another risk factor for injuries21,26,30,33.

4.1.5. Conclusion
The risk of injuries for the general epilepsy population is
increased only moderately. The risk is higher in selected populations attending epilepsy clinics and referral centers. But
even among people with more severe epilepsy the majority
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will not sustain significant seizure-related injuries. This being
said, there are PWE that suffer frequent, severe, and sometimes even life-threatening seizure-related injuries. Some risk
factors have been identified and the most obvious way to
reduce risks is to strive for improved seizure control.
Measures that reduce the risk of seizure-related injuries, such
as work place and home adjustments, should also be considered in particular for those that continue to have seizures
associated with falls.

5. Mortality in people with epilepsy
People with epilepsy have a 2–3 times higher mortality rate
than the general populatio36. The standardized mortality
ratio (SMR) is the most commonly used measure to describe
increased mortality risk. In an early study, the SMR was 2.3
through 29 years of follow-up37. The most significant increase
in SMR was noted early after diagnosis38. The SMR depended
on seizure type and seizure control status. Generalized tonicclonic seizures were associated with increased mortality, but
absence seizures were not37. A recent review of epilepsy
mortality in high-income countries reported an SMR range of
1.6–3, with a weighted median SMR of 2.3 for all ages39. A
similar review of mortality in low- and middle-income countries found an SMR range of 1.3–7.2 with a weighted median
of 2.640. SMR was higher in children, likely because of low
expected mortality from other causes in the general pediatric
population, and SMR was lower after age 60, likely related to
increased expected mortality from other causes in the
older age group. SMR was consistently more elevated for
individuals with convulsive seizures (as compared with nonconvulsive seizures) and for those with structural-metabolic
causes of epilepsy (as compared with genetic or unknown
etiology). The highest mortality was found in epilepsy
patients with epileptic encephalopathies39, and intellectual
disability or cerebral palsy41. The risk of mortality was higher
among those with uncontrolled seizures versus those who
were seizure-free39. Patients who became seizure-free after
epilepsy surgery had a lower mortality rate than non-seizurefree patients42.

5.1. Causes of mortality
Deaths in PWE may relate to the underlying cause of epilepsy, to seizures (including sudden unexpected death in epilepsy- SUDEP) and to status epilepticus, as well as to other
conditions that do not appear directly related to epilepsy43.
Increased mortality was seen as a result of cerebrovascular
disease, pneumonia, and neoplastic disorders, even after
exclusion of primary brain tumors41. In a community-based
cohort with 25 years of follow-up the most common cause of
death was a comorbid condition, most commonly noncerebral neoplasm, cardiovascular disease, and cerebrovascular
disease, which accounted for 59% of deaths The epilepsy etiology was the cause of death in 23%, and epilepsy-related
causes accounted for 3%44. It is likely that seizure- and epilepsy-related mortality is underestimated, largely because the
role of epilepsy is ignored or other less likely causes of death

are listed on the death certificate even though criteria for
SUDEP are satisfied45. Causes of epilepsy/seizure-related mortality include drownings, suicides, and fatal unintentional
injuries45. The risk of drowning increased with an SMR of
18.746, and was particularly high in people with epilepsy and
learning disability (SMR ¼ 25.7), subjects in institutional care
(SMR ¼ 96.9), and in people who had a temporal lobe excision (SMR ¼ 41.1)46. Risk of suicide also increased with a
SMR of 4.847. Mortality was increased by non-adherence to
epilepsy treatment, with a three-fold increased risk of mortality48. Non-adherence to medications as well as limited access
to treatment may be responsible for the higher mortality in
low- and middle-income countries, at least in part40.

5.2. Sudden unexpected death in epilepsy (SUDEP)
SUDEP is defined as “sudden, unexpected, witnessed or
unwitnessed, non-traumatic and non-drowning death, occurring in benign circumstances, in an individual with epilepsy,
with or without evidence for a seizure and excluding documented status epilepticus”49. SUDEP is the most common
cause of epilepsy-related death, with a 27-fold higher rate of
sudden death than in controls50, and an annual rate of
around 12 per 10,000 PWE45. The risk of SUDEP was 1–4
times higher in male than female patients51. Definite SUDEP
requires a postmortem examination showing no definite
cause of death. If a postmortem examination is not performed but the definition is otherwise fulfilled, probable
SUDEP can be diagnosed49. Possible SUDEP applies to instances where there may be competing possible causes of death.
There is strong evidence that SUDEP is seizure-related52.
When SUDEP is witnessed it is most often associated with a
bilateral convulsive seizure near the time of death53,54.
SUDEP was primarily sleep-related and unwitnessed55. The
vast majority of unwitnessed SUDEP was associated with
tongue biting or incontinence, suggesting recent tonic-clonic
seizures56. In a case-control study, supervision at night was
protective when a supervising individual shared the same
bedroom or when special precautions such as listening
device were employed56. Other risk factors include longer
duration of epilepsy and structural-metabolic etiology57. The
frequency of bilateral tonic-clonic seizures was the prominent
risk factor for SUDEP in a study58. After adjusting for tonicclonic seizure frequency, analysis of individual anti-seizure
medications and number of antiseizure medications
revealed no associated increased risk58. In fact, antiseizure
medication levels were often sub-therapeutic in SUDEP
patients59. A strong evidence that SUDEP is seizure-related
came from a meta-analysis of 112 adjunctive anti-seizure
medication trials60. Rates of definite or probable SUDEP per
1000 person-years were 0.9 in patients who received efficacious antiseizure medication doses and 6.9 in those receiving
adjunctive placebo. There was a strong association of SUDEP
and prone position when body position was documented61,
showing the similarity between SUDEP and sudden infant
death syndrome. There is increasing evidence that a centrally
mediated respiratory depression is involved in SUDEP. Ictal
apnea and hypoxia are common, even in focal seizures that
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do not progress to bilateral tonic-clonic activity62. Serotonin
reuptake inhibitors were reported to reduce the likelihood of
oxygen desaturation during focal seizures63. Apnea was elicited by electrical stimulation of the amygdala64, and ictal
apnea was correlated with seizure spread to the amygdala65.
Patients who later died from SUDEP often had postictal generalized EEG suppression, thought to reflect profound cerebral dysfunction, possibly a factor in central apnea66. The
early administration of oxygen after seizure onset seemed to
prevent this postictal generalized EEG suppression67.
Improving seizure control and patient education may be
the most important measures to reduce epilepsy-related
mortality in general and SUDEP in particular. A recent survey
of 519 Austrian, Swiss and German neurologists and neuropediatricians showed that premature mortality due to SUDEP
or suicidality are not discussed at all with PWE by a substantial proportion of neurologists and neuropediatricians68.
Patients at risk for SUDEP need to be informed about this
potential complication69. This is particularly true for those
who are not compliant with their medications and those
with drug-resistant epilepsy who are excellent candidates for
epilepsy surgery70.

6. Injuries and mortality in childhood epilepsies
Injuries that may be sustained as a result of the unpredictable occurrence of convulsive seizures remain a constant
source of concern to parents and carers of children, particularly those with complex epilepsy. Despite the likelihood of a
higher rate of supervision, studies suggest that injuries from
seizures are a serious persistent problem in childhood epilepsy. Camfield and Camfield utilized the Nova Scotia population based cohort to ask whether children had ever
experienced an accident that was sufficiently concerning to
lead to an emergency room visit or a visit with a family
physician or a dentist. In >90% this was for a duration
>10 years following the onset of epilepsy, and included individuals with all types of epilepsy except absence epilepsy. Of
595 eligible patients, 472 answered the questions, of whom
51 reported 81 such injuries23. Such injuries included lacerations requiring suture (30%), bone fractures (19%), broken
teeth (14%), concussion (10%), burns (5%) and shoulder dislocation (4%). These could occur at any period of time after
the onset of the epilepsy. There did not appear to be any
particular association with the type of epilepsy but there was
an increased association with the presence of intellectual disability and continuing seizures. With regard to any risk and
absence epilepsy (AE) this was previously examined in a similar cohort by Wirrell et al., and risk compared to a cohort
with juvenile rheumatoid arthritis (JRA)71. These individuals
were questioned as adults with regard to all previous accidental injuries, including nature, severity, and treatment
required; those with a history of AE were additionally asked
as to whether they had ever sustained injury during an
absence seizure. Patients with AE had a greater number of
overall accidental injuries than those with JRA (p < .04), but
these differences were particularly marked for bicycle (p <
.003) and car accidents (p < .05) and for mild head injuries
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(p ¼ .05). Sixteen (27%) of 59 patients with AE reported accidental injury during an absence seizure, the risk was higher
in absences associated with juvenile myoclonic epilepsy than
in juvenile absence or childhood absence epilepsies, the risk
being particularly low in the latter. A further case control
study found that individuals with uncomplicated childhood
epilepsy (normal IQ and neurological examination), were no
more at risk of injury than sibling controls except for head
injuries, and were much less likely to experience injury than
individuals with complicated epilepsy (IQ <80 or abnormal
neurological examination)72. One question that may arise
however is whether there is a risk of injury in newly diagnosed or prior to the diagnosis of epilepsy; this is specifically,
important when counselling for risk after a first seizure. A
prospective study of newly diagnosed and untreated patients
across seven centers determined 25/198 who experienced an
injury before a diagnosis was established, 4 requiring medical
attention, the majority in association with tonic-clonic seizures. However, none of the patients with childhood absence
epilepsy reported injury73.
As highlighted above, the SMR for children is higher, likely
because of low expected mortality from other causes in the
general pediatric population. One study combined data from
four epidemiological cohorts; three prospective (Connecticut,
the Netherland and Nova Scotia) and one retrospective
(Rochester)74. This revealed overall mortality rates of 2.28 per
1000 person years, but much higher rates again for complicated (7.43) compared to uncomplicated (0.36) epilepsy, suggesting comorbidities had high relevance. In a UK
surveillance study where all pediatricians in the UK and
Ireland were asked monthly as to whether they had seen a
case over a 12-month period, of 88 confirmed cases 73/81,
where data were available, had the existence of comorbidities. 51% were the result of pneumonia, sepsis or underlying
genetic or metabolic conditions75. Accidents were not listed,
but reviewing from a different angle, a study of drowning
fatalities and the role of pre-existing medical conditions
found epilepsy to increase the relative risk of drowning in
childhood, with a prevalence of 4.1% of drowning deaths
compared with 0.7–1.7% among the general population. No
other identified pre-existing medical condition was associated with an increased risk of drowning76. Anti-epileptic
drug association was also not listed considering adverse
reactions to medication could be considered a risk. A study
reviewing the causality of death in children on AEDs determined that the majority who died had underlying disorders
as in other studies77. Of 151 deaths (in 6190 subjects), 18
were epilepsy related and 5 likely (2 definite and 3 possible)
related to AEDs. In addition, two status epilepticus deaths
were an epilepsy-related death, data suggest that in the
acute phase, death if it occurs is related to the underlying
cause (e.g. bacterial meningitis)78,79 and in the longer term
predominantly seen in those with pre-existent neurological
abnormality80.
Traditionally, there has been a belief that SUDEP is a
lesser risk in childhood; the combined cohort suggested an
incidence of 0.33/1000 person years74 and the American
Academy of Neurology after a systematic review of the
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literature suggested an incidence of 0.22/1000 person years,
quoting it affecting 1 in 4500 children per year compared to
1 in 1000 adults81. One could consider this might be the
case, specifically as the risk has been suggested to be lower
in supervised facilities; a study of SUDEP in a residential
school revealing all deaths to occur when the pupils were
not under the close supervision of the school82. However,
two registry studies have determined incidence of definite
and probable SUDEP similar to that seen in adults; the
Swedish study of SUDEP in 2008 showing an incidence of
1.11/1000 person years in <16 years, and 1.13 16–50 years83,
and in another study of SUDEP in children <18 years the
incidence was 1.1/1000 person years, rising to 1.45 after capture recapture correction84 suggesting the risk is no different
in children to adults. A recently published systematic review
highlighted risk factors linked to SUDEP in children of early
age at onset, high seizure frequency, intellectual impairment,
multiple AED therapy and structural abnormalities on MRI
scan85. All these of course may be related to the severity or
complexity of the epilepsy; certainly, the rate of SUDEP in
Dravet syndrome, a specific early onset epilepsy associated
with continuing seizures and intellectual impairment despite
treatment has been shown to be relatively higher at 9.32/
1000 person years, with overall mortality rate of 15.84/1000
person years perhaps reflecting associated comorbidities86.
Acknowledging children with a sodium channel mutation
may be at increased risk for a multitude of reasons, all syndromes with continued convulsive seizures however appear
to carry a risk87. Recent evidence suggests that the appropriate involvement of tertiary specialists in pediatric care may
decrease all-cause mortality. A recent study has shown where
eligible patients, including those with more complex epilepsies, are seen by a pediatric neurologist there is an overall
reduction in total mortality as well as mortality post
transition88.

7. Conclusion
While this review could only provide highlights and could
not be comprehensive in view of its broad subject matter,
we can conclude that people with epilepsy may have dramatic life experiences, such as depression, injuries, and premature mortality. Considering the high prevalence of
depression among PWE, particularly in women, routine and
periodic screening of all PWE for early detection and appropriate management of depression is advised. All PWE should
also be screened for suicidal ideation regularly and if necessary, patients should be referred for a psychiatric evaluation
and treatment. The risk of injuries for the general epilepsy
population is increased only moderately. The risk is higher in
selected populations attending epilepsy clinics and referral
centers. This being said, there are PWE that may suffer frequent, severe, and sometimes even life-threatening seizurerelated injuries. Seizure-related injuries often occur at home
and therefore, simple considerations (e.g. supervised bathing,
using microwave ovens instead of classical stoves, and sleeping close to the floor to avoid falling) may reduce the incidence of seizure-related injuries89. The most obvious way to

reduce risks is to strive for improved seizure control. Finally,
PWE have a higher mortality rate than the general population; children are equally at risk to adults. Improving specialist care, seizure control and patient education may be
the most important measures to reduce epilepsy
related mortality.
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Cengiz O, Atalar AÇ, Tekin B, et al. Impact of seizure-related injuries on quality of life. Neurol Sci. 2019;40(3):577–583.

